Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 29, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Validation for soluble C5b-9 detection and comparative analysis of three quantification methods.

Tracie Profaizer1, Abdulrahman Saadalla2, Vijayalakshmi Nandakumar3

  • 1ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States of America.

Journal of Immunological Methods
|May 24, 2025
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

CLOCK is an Epigenetic Integrator of Circadian Rhythm and T Cell Immunity.

Research square·2026
Same author

Reply.

The Journal of allergy and clinical immunology·2026
Same author

Estimation of serum tryptase reference intervals via an indirect method reveal age- and sex-dependent upper limits.

The Journal of allergy and clinical immunology·2026
Same author

Determination of Fibrinogen Ratio Cutoff Limits Using Indirect Reference Interval Methodology.

International journal of laboratory hematology·2025
Same author

The Utility of the Immunoglobulin A Flag Used in Celiac Disease Serology Testing on a Particle-Based Multianalyte Technology Platform.

Clinical chemistry·2025
This summary is machine-generated.

The Quidel sC5b-9 ELISA kit accurately detects complement activation, but the Hycult assay provides a wider dynamic range for monitoring complement inhibitor therapy. Both assays show effectiveness in therapeutic assessments.

Area of Science:

  • Immunology
  • Biochemistry
  • Clinical Diagnostics

Background:

  • Soluble C5b-9 (sC5b-9) is a key biomarker for complement system activation.
  • sC5b-9 measurement is crucial for diagnosing conditions like thrombotic microangiopathy and monitoring complement inhibitor therapies.
  • Accurate sC5b-9 detection aids therapeutic decisions, especially for patients on anti-C5 inhibitors.

Purpose of the Study:

  • To validate the Quidel sC5b-9 ELISA kit for detecting complement activation.
  • To compare the performance of the Quidel sC5b-9 ELISA kit with Hycult and SVAR assays.
  • To assess assay linearity and suitability for therapeutic monitoring.

Main Methods:

  • Analytical performance evaluation of the Quidel sC5b-9 ELISA kit using split samples.
Keywords:
Complement-mediated activationELISAEculizumabTerminal complement Cascade (TCC)Thrombotic microangiopathy (TMA)sC5b-9

More Related Videos

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Quantitative and Qualitative Method for Sphingomyelin by LC-MS Using Two Stable Isotopically Labeled Sphingomyelin Species
08:53

Quantitative and Qualitative Method for Sphingomyelin by LC-MS Using Two Stable Isotopically Labeled Sphingomyelin Species

Published on: May 7, 2018

Related Experiment Videos

Last Updated: May 29, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Quantitative and Qualitative Method for Sphingomyelin by LC-MS Using Two Stable Isotopically Labeled Sphingomyelin Species
08:53

Quantitative and Qualitative Method for Sphingomyelin by LC-MS Using Two Stable Isotopically Labeled Sphingomyelin Species

Published on: May 7, 2018

  • Assessment of precision, sensitivity, linearity, and reference limits with artificially activated samples and patient samples.
  • Correlation analysis between Quidel, Hycult, and SVAR assays, and comparison of linear ranges.
  • Evaluation of the impact of anti-C5 inhibitors on sC5b-9 concentrations.
  • Main Results:

    • The Quidel sC5b-9 assay demonstrated accuracy (R²=0.90) and high qualitative concordance (93.3%).
    • The reportable range for the Quidel assay was determined as 220-1800 ng/mL, with LOQ at 170 ng/mL.
    • The Hycult kit exhibited a broader linear range compared to Quidel and SVAR assays, maintaining linearity at higher concentrations.
    • All tested assays showed reduced sC5b-9 levels after anti-C5 inhibitor addition, with Hycult maintaining a wide dynamic range.

    Conclusions:

    • The Quidel sC5b-9 ELISA kit is a reliable tool for detecting complement activation and inhibition.
    • The Hycult assay's broader dynamic range is advantageous for disease monitoring and therapeutic assessments.
    • Assay selection should consider the specific requirements for sensitivity and dynamic range in clinical applications.